Uniphar Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 2/6

Uniphar yıllık ortalama 17.2% oranında kazançlarını artırırken, Healthcare sektöründe kazançlar growing at 31.3% annual. Gelirler growing yılda ortalama 10.3% oranında artmaktadır. Uniphar'in özkaynak karlılığı 13% ve net marjı 1.7%'dir.

Anahtar bilgiler

17.2%

Kazanç büyüme oranı

8.8%

EPS büyüme oranı

Healthcare Sektör Büyümesi	12.6%
Gelir büyüme oranı	10.3%
Özkaynak getirisi	13.0%
Net Marj	1.7%
Son Kazanç Güncellemesi	30 Jun 2024

Yakın geçmiş performans güncellemeleri

Recent updates

Gelir ve Gider Dağılımı

Uniphar nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.

Kazanç ve Gelir Geçmişi

AIM:UPR Gelir, gider ve kazançlar (EUR Millions )
Tarih	Gelir	Kazançlar	G+A Giderleri
30 Jun 24	2,681	45	329
31 Mar 24	2,617	45	321
31 Dec 23	2,553	45	313
30 Sep 23	2,436	45	294
30 Jun 23	2,318	45	276
31 Mar 23	2,195	45	257
31 Dec 22	2,071	46	237
30 Sep 22	2,020	47	232
30 Jun 22	1,970	49	226
31 Mar 22	1,957	48	222
31 Dec 21	1,943	48	217
30 Sep 21	1,930	39	206
30 Jun 21	1,917	30	195
31 Mar 21	1,871	29	183
31 Dec 20	1,824	28	171
30 Sep 20	1,780	26	164
30 Jun 20	1,736	25	158
31 Mar 20	1,701	23	149
31 Dec 19	1,665	21	141
30 Sep 19	1,607	20	130
30 Jun 19	1,549	19	119
31 Mar 19	1,484	14	105
31 Dec 18	1,418	9	92
31 Dec 17	1,265	-2	83
31 Dec 16	1,294	5	79
31 Dec 15	1,117	6	60
31 Dec 14	1,129	-19	68
31 Dec 13	860	-18	39

Kaliteli Kazançlar: UPR yüksek kaliteli kazançlar sağlıyor.

Büyüyen Kar Marjı: UPR 'nin mevcut net kar marjları (1.7%) geçen yılın (1.9%) değerinden daha düşüktür.

Serbest Nakit Akışı ve Kazanç Analizi

Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: UPR şirketinin kazancı son 5 yılda yılda 17.2% oranında arttı.

Büyüme Hızlandırma: UPR 'un son bir yıldaki kazanç büyümesi ( 1.4% ) 5 yıllık ortalamasının ( 17.2% /yıl) altındadır.

Kazançlar vs. Sektör: UPR geçen yılki kazanç büyümesi ( 1.4% ) Healthcare sektörünün 15.6% performansını geride bırakmadı.

Özkaynak Getirisi

Yüksek ROE: UPR 'nin Özsermaye Getirisi ( 13% ) düşük olarak değerlendiriliyor.

Uniphar Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 2/6

Anahtar bilgiler

Yakın geçmiş performans güncellemeleri

First half 2024 earnings released: EPS: €0.056 (vs €0.055 in 1H 2023)

Uniphar plc to Report First Half, 2024 Results on Sep 03, 2024

Full year 2023 earnings released

Uniphar plc to Report Fiscal Year 2023 Results on Feb 27, 2024

First half 2023 earnings released

Uniphar plc to Report First Half, 2023 Results on Sep 14, 2023

Recent updates

First half 2024 earnings released: EPS: €0.056 (vs €0.055 in 1H 2023)

Uniphar plc to Report First Half, 2024 Results on Sep 03, 2024

Upcoming dividend of €0.012 per share

Uniphar plc, Annual General Meeting, May 09, 2024

Final dividend of €0.012 announced

Uniphar plc Recommends Final Dividend, Payable on 14 May 2024

Full year 2023 earnings released

Insufficient new directors

Uniphar plc to Report Fiscal Year 2023 Results on Feb 27, 2024

Uniphar plc Announces Resignation of Jeffrey Berkowitz from the Board

Now 21% undervalued after recent price drop

Senior Independent Director recently bought UK£99k worth of stock

Now 20% undervalued after recent price drop

First half 2023 earnings released

Uniphar plc Declares Interim Dividend for the Period to 30 June 2023, Payable on 20 October 2023

Now 21% undervalued after recent price drop

Uniphar Group Appoints Kay Bonavita as Chief Commercial Officer for Uniphar Logistics to Lead the US Team Based Out of Raleigh, North Carolina

Uniphar plc to Report First Half, 2023 Results on Sep 14, 2023

Upcoming dividend of €0.011 per share at 0.6% yield

CEO & Executive Director recently sold UK£807k worth of stock

Full year 2022 earnings released

Uniphar plc to Report Fiscal Year 2022 Results on Feb 28, 2023

Uniphar plc (ISE:UPR) acquired Bmodesto B.V for EUR 75 million.

Now 22% undervalued

Uniphar plc (ISE:UPR) acquired Inspired Health.

Uniphar plc (ISE:UPR) acquired McCauley Health & Beauty Pharmacy Limited.

Uniphar plc Declares Interim Dividend, Payable on October 6, 2022

Uniphar Reportedly in Talks to Buy Sam McCauley

Uniphar Reportedly in Talks to Buy Sam McCauley

High number of new directors

Now 20% undervalued after recent price drop

Uniphar plc to Report First Half, 2022 Results on Aug 30, 2022

Now 22% undervalued after recent price drop

High number of new directors

Upcoming dividend of €0.011 per share

Uniphar plc, Annual General Meeting, May 11, 2022

Investor sentiment improved over the past week

Senior Independent Director recently bought UK£119k worth of stock

Full year 2021 earnings: Revenues in line with analyst expectations

Uniphar plc (ISE:UPR) agreed to acquire Navi Group.

CEO & Executive Director recently sold UK£1.9m worth of stock

First half 2021 earnings released: EPS €0.057 (vs €0.049 in 1H 2020)

Uniphar plc (ISE : UPR) acquired BESTMSLs Group.

Uniphar plc Approves Final Dividend

Upcoming dividend of €0.015 per share

Full year 2020 earnings released: EPS €0.11 (vs €0.12 in FY 2019)

Full year 2020 earnings released

Revenue beats expectations

New 90-day high: UK£2.40

Investor sentiment improved over the past week

Non-Executive Director has left the company

Uniphar plc Announces Directorate Changes

Uniphar plc to Report Fiscal Year 2020 Results on Mar 02, 2021

New 90-day high: €2.62

Uniphar plc (ISE:UPR) acquired RRD International, LLC.

Uniphar plc (ISE:UPR) completed the acquisition of Hickey's Pharmacy Ltd. from Hickey family.

New 90-day high: €2.55

Uniphar plc (ISE:UPR) acquired Diligent Health Solutions, LLC for $27 million.

Senior Independent Director recently bought €82k worth of stock

Uniphar plc Announces Directorate Change

Non-Executive Director recently sold €834.4k worth of stock

New 90-day high - €2.51

First half earnings released

Uniphar plc (ISE:UPR) reached an agreement to acquire Hickey's Pharmacy Ltd. from Hickey family.

New 90-day high - €2.23

Uniphar plc to Report First Half, 2020 Results on Sep 02, 2020

New 90-day high - €1.98

Gelir ve Gider Dağılımı

Kazanç ve Gelir Geçmişi